Protagenic Therapeutics, Inc. (PTIX)
OTCMKTS · Delayed Price · Currency is USD
0.5300
-0.040075 (-7.03%)
At close: Apr 2, 2026
Protagenic Therapeutics Market Cap
Protagenic Therapeutics has a market cap or net worth of $959.41 thousand as of April 6, 2026.
Market Cap
959.41K
Enterprise Value
2.74M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.53
Market Cap Chart
Since May 19, 2025, Protagenic Therapeutics's market cap has decreased from 9.64M to 959.41K, a decrease of -90.05%. That is a compound annual growth rate of -92.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 959.41K | -61.86% |
| Dec 31, 2025 | 2.52M | -73.91% |
| May 19, 2025 | 9.64M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| International Stem Cell | 1.36M |
| CERo Therapeutics Holdings | 1.22M |
| Scorpius Holdings | 1.22M |
| Avenue Therapeutics | 1.15M |
| Evofem Biosciences | 1.10M |
| Eastgate Biotech | 1.06M |
| Emmaus Life Sciences | 1.05M |
| Lyra Therapeutics | 870.23K |